company background image
ASTEC logo

Astec LifeSciences NSEI:ASTEC 株式レポート

最終価格

₹1.18k

時価総額

₹23.2b

7D

-4.3%

1Y

-10.8%

更新

28 Sep, 2024

データ

会社財務 +

Astec LifeSciences Limited

NSEI:ASTEC 株式レポート

時価総額:₹23.2b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

ASTEC 株式概要

アステック・ライフサイエンシズ社は、その子会社とともに、インドにおいて農薬原体および医薬中間体の製造・販売を行っている。

ASTEC ファンダメンタル分析
スノーフレーク・スコア
評価0/6
将来の成長5/6
過去の実績0/6
財務の健全性2/6
配当金0/6

Astec LifeSciences Limited 競合他社

価格と性能

の歴代最高値、変動、値下がりまとめAstec LifeSciences
過去の株価
現在の株価₹1,181.10
52週高値₹1,474.40
52週安値₹825.05
ベータ0.30
11ヶ月の変化-1.64%
3ヶ月変化-9.24%
1年変化-10.77%
33年間の変化-8.10%
5年間の変化209.35%
IPOからの変化1,306.07%

最新ニュース

Shareholders May Be Wary Of Increasing Astec LifeSciences Limited's (NSE:ASTEC) CEO Compensation Package

Jul 23
Shareholders May Be Wary Of Increasing Astec LifeSciences Limited's (NSE:ASTEC) CEO Compensation Package

Recent updates

Shareholders May Be Wary Of Increasing Astec LifeSciences Limited's (NSE:ASTEC) CEO Compensation Package

Jul 23
Shareholders May Be Wary Of Increasing Astec LifeSciences Limited's (NSE:ASTEC) CEO Compensation Package

Market Participants Recognise Astec LifeSciences Limited's (NSE:ASTEC) Revenues Pushing Shares 28% Higher

Jul 03
Market Participants Recognise Astec LifeSciences Limited's (NSE:ASTEC) Revenues Pushing Shares 28% Higher

Astec LifeSciences Limited (NSE:ASTEC) Stocks Shoot Up 30% But Its P/S Still Looks Reasonable

Mar 15
Astec LifeSciences Limited (NSE:ASTEC) Stocks Shoot Up 30% But Its P/S Still Looks Reasonable

Astec LifeSciences (NSE:ASTEC) Could Be Struggling To Allocate Capital

May 17
Astec LifeSciences (NSE:ASTEC) Could Be Struggling To Allocate Capital

Shareholders Are Optimistic That Astec LifeSciences (NSE:ASTEC) Will Multiply In Value

Oct 14
Shareholders Are Optimistic That Astec LifeSciences (NSE:ASTEC) Will Multiply In Value

We Ran A Stock Scan For Earnings Growth And Astec LifeSciences (NSE:ASTEC) Passed With Ease

Jul 27
We Ran A Stock Scan For Earnings Growth And Astec LifeSciences (NSE:ASTEC) Passed With Ease

Here's Why Astec LifeSciences (NSE:ASTEC) Can Manage Its Debt Responsibly

Jun 28
Here's Why Astec LifeSciences (NSE:ASTEC) Can Manage Its Debt Responsibly

A Look At The Intrinsic Value Of Astec LifeSciences Limited (NSE:ASTEC)

Jun 03
A Look At The Intrinsic Value Of Astec LifeSciences Limited (NSE:ASTEC)

Analysts Just Published A Bright New Outlook For Astec LifeSciences Limited's (NSE:ASTEC)

May 08
Analysts Just Published A Bright New Outlook For Astec LifeSciences Limited's (NSE:ASTEC)

Astec LifeSciences Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

May 06
Astec LifeSciences Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Why We Like The Returns At Astec LifeSciences (NSE:ASTEC)

Jan 25
Why We Like The Returns At Astec LifeSciences (NSE:ASTEC)

Is Astec LifeSciences (NSE:ASTEC) A Risky Investment?

Dec 13
Is Astec LifeSciences (NSE:ASTEC) A Risky Investment?

We Take A Look At Why Astec LifeSciences Limited's (NSE:ASTEC) CEO Has Earned Their Pay Packet

Jul 21
We Take A Look At Why Astec LifeSciences Limited's (NSE:ASTEC) CEO Has Earned Their Pay Packet

Does Astec LifeSciences (NSE:ASTEC) Have A Healthy Balance Sheet?

May 02
Does Astec LifeSciences (NSE:ASTEC) Have A Healthy Balance Sheet?

The Trend Of High Returns At Astec LifeSciences (NSE:ASTEC) Has Us Very Interested

Apr 17
The Trend Of High Returns At Astec LifeSciences (NSE:ASTEC) Has Us Very Interested

Do Astec LifeSciences's (NSE:ASTEC) Earnings Warrant Your Attention?

Apr 02
Do Astec LifeSciences's (NSE:ASTEC) Earnings Warrant Your Attention?

Is Astec LifeSciences Limited's (NSE:ASTEC) Shareholder Ownership Skewed Towards Insiders?

Mar 18
Is Astec LifeSciences Limited's (NSE:ASTEC) Shareholder Ownership Skewed Towards Insiders?

Have Insiders Been Selling Astec LifeSciences Limited (NSE:ASTEC) Shares?

Mar 05
Have Insiders Been Selling Astec LifeSciences Limited (NSE:ASTEC) Shares?

Did You Miss Astec LifeSciences' (NSE:ASTEC) Whopping 481% Share Price Gain?

Feb 20
Did You Miss Astec LifeSciences' (NSE:ASTEC) Whopping 481% Share Price Gain?

A Look At Astec LifeSciences' (NSE:ASTEC) CEO Remuneration

Feb 08
A Look At Astec LifeSciences' (NSE:ASTEC) CEO Remuneration

Declining Stock and Solid Fundamentals: Is The Market Wrong About Astec LifeSciences Limited (NSE:ASTEC)?

Jan 28
Declining Stock and Solid Fundamentals: Is The Market Wrong About Astec LifeSciences Limited (NSE:ASTEC)?

What Does Astec LifeSciences Limited's (NSE:ASTEC) Share Price Indicate?

Jan 17
What Does Astec LifeSciences Limited's (NSE:ASTEC) Share Price Indicate?

Why We Like The Returns At Astec LifeSciences (NSE:ASTEC)

Jan 08
Why We Like The Returns At Astec LifeSciences (NSE:ASTEC)

I Ran A Stock Scan For Earnings Growth And Astec LifeSciences (NSE:ASTEC) Passed With Ease

Dec 28
I Ran A Stock Scan For Earnings Growth And Astec LifeSciences (NSE:ASTEC) Passed With Ease

Is Astec LifeSciences Limited (NSE:ASTEC) Popular Amongst Insiders?

Dec 18
Is Astec LifeSciences Limited (NSE:ASTEC) Popular Amongst Insiders?

Astec LifeSciences (NSE:ASTEC) Is Growing Earnings But Are They A Good Guide?

Dec 07
Astec LifeSciences (NSE:ASTEC) Is Growing Earnings But Are They A Good Guide?

Does Astec LifeSciences (NSE:ASTEC) Have A Healthy Balance Sheet?

Nov 27
Does Astec LifeSciences (NSE:ASTEC) Have A Healthy Balance Sheet?

Ashok Hiremath Is The MD & Director of Astec LifeSciences Limited (NSE:ASTEC) And They Just Sold 35% Of Their Shares

Nov 17
Ashok Hiremath Is The MD & Director of Astec LifeSciences Limited (NSE:ASTEC) And They Just Sold 35% Of Their Shares

株主還元

ASTECIN ChemicalsIN 市場
7D-4.3%0.9%1.3%
1Y-10.8%28.9%45.4%

業界別リターン: ASTEC過去 1 年間で25.4 % の収益を上げたIndian Chemicals業界を下回りました。

リターン対市場: ASTECは、過去 1 年間で43.6 % のリターンを上げたIndian市場を下回りました。

価格変動

Is ASTEC's price volatile compared to industry and market?
ASTEC volatility
ASTEC Average Weekly Movement5.4%
Chemicals Industry Average Movement5.7%
Market Average Movement6.2%
10% most volatile stocks in IN Market9.3%
10% least volatile stocks in IN Market3.9%

安定した株価: ASTEC過去 3 か月間に大きな価格変動はありませんでした。

時間の経過による変動: ASTECの 週次ボラティリティ ( 6% ) は過去 1 年間安定しています。

会社概要

設立従業員CEO(最高経営責任者ウェブサイト
1994606Anurag Roywww.godrejastec.com

Astec LifeSciences Limited は、子会社とともにインドで農薬活性成分および医薬中間体の製造・販売を行っている。畑作用のトリアゾール系殺菌剤、かさぶた病、うどんこ病、ショットホール病、花枯病、さび病防除のための葉面処理剤、綿花やトウモロコシ、大麦、米、小麦などの穀物における種子および土壌伝染性病害防除のための種子処理剤、ポストハーベストドレンチ、食品添加物、木材保存剤などを提供している。また、除草剤、殺虫剤、特殊化学製品も提供している。製品の輸出も行っている。同社は1994年に設立され、インドのムンバイを拠点としている。Astec LifeSciences Limited は Godrej Agrovet Limited の子会社である。

Astec LifeSciences Limited 基礎のまとめ

Astec LifeSciences の収益と売上を時価総額と比較するとどうか。
ASTEC 基礎統計学
時価総額₹23.16b
収益(TTM)-₹784.59m
売上高(TTM)₹3.85b

6.0x

P/Sレシオ

-29.5x

PER(株価収益率

収益と収入

最新の決算報告書(TTM)に基づく主な収益性統計
ASTEC 損益計算書(TTM)
収益₹3.85b
売上原価₹3.04b
売上総利益₹813.05m
その他の費用₹1.60b
収益-₹784.59m

直近の収益報告

Jun 30, 2024

次回決算日

該当なし

一株当たり利益(EPS)-40.01
グロス・マージン21.11%
純利益率-20.37%
有利子負債/自己資本比率133.7%

ASTEC の長期的なパフォーマンスは?

過去の実績と比較を見る